ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 110 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2,659,386 | +4.5% | 175,537 | +18.7% | 0.01% | -23.1% |
| Q1 2023 | $2,544,276 | -13.5% | 147,923 | +1.3% | 0.01% | -18.8% |
| Q4 2022 | $2,941,024 | -35.2% | 146,029 | -30.3% | 0.02% | -33.3% |
| Q3 2022 | $4,536,000 | -42.2% | 209,434 | -25.1% | 0.02% | -41.5% |
| Q2 2022 | $7,854,000 | +29.0% | 279,510 | +111.8% | 0.04% | +17.1% |
| Q1 2022 | $6,088,000 | -14.7% | 131,940 | +55.4% | 0.04% | -10.3% |
| Q4 2021 | $7,138,000 | +126.3% | 84,912 | +79.4% | 0.04% | +95.0% |
| Q3 2021 | $3,154,000 | +118.7% | 47,322 | +74.5% | 0.02% | +100.0% |
| Q2 2021 | $1,442,000 | – | 27,114 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 2,099,583 | $42,117,635 | 14.06% |
| Mayo Clinic | 187,143 | $3,754,089 | 7.23% |
| Matrix Capital Management Company, LP | 13,959,973 | $280,037,058 | 3.36% |
| 5AM Venture Management, LLC | 490,000 | $9,829,400 | 2.83% |
| Eventide Asset Management | 7,814,039 | $156,749,622 | 2.82% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $19,287,410 | 2.70% |
| Avidity Partners Management LP | 2,100,000 | $42,126,000 | 1.70% |
| First Light Asset Management, LLC | 848,477 | $17,020,449 | 1.62% |
| Sofinnova Investments, Inc. | 1,211,641 | $24,305,518 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 386,525 | $7,753,692 | 1.51% |